eoadjuvant chemotherpy with gemcitabine and oral S-1for pancreatic cancer
Phase 1
- Conditions
- resectable pancreatic cancer
- Registration Number
- JPRN-UMIN000011064
- Lead Sponsor
- Department of Gastroenterologic Surgery, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with anti-cancer agent administration in history past 2) Active another cancer 3) Severe complications 4) Patients with interstitial pneumonia or pulmonary fibrosis 5) Active infection 6) Pregnant woman 7) Severe mental disorder 8) Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of the recommended dose
- Secondary Outcome Measures
Name Time Method